74P Predicting the risk of immunotherapy-induced versus other-cause pneumonitis in stage IV non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors
Autor: | F. Tohidinezhad, L. Hendriks, A-M.C. Dingemans, J.G. Aerts, G. Bootsma, J.F. Vansteenkiste, S. Hashemi, E.F. Smit, H. Gietema, H.J. Aerts, A. Dekker, A. Traverso, D. De Ruysscher |
---|---|
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Annals of Oncology. 32:S1404 |
ISSN: | 0923-7534 |
DOI: | 10.1016/j.annonc.2021.10.092 |
Databáze: | OpenAIRE |
Externí odkaz: |